Victoria Rollason
- Pharmacology top 1%
- Geriatrics and Gerontology top 1%
- Pediatrics, Perinatology and Child Health top 5%
- Oncology
- Pharmacology top 5%
- Co-authors
- Jules DesmeulesNicole P. VogtCaroline SamerYoussef DaaliKuntheavy Ing LorenziniCamille LenoirGürkan KayaPierre Dayer
- Topics
- Pharmacogenetics and Drug Metabolism (19 papers)Pharmacovigilance and Adverse Drug Reactions (8 papers)Atrial Fibrillation Management and Outcomes (6 papers)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Victoria Rollason
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 124
- Pharmacology 363
- Geriatrics and Gerontology 228
- Pediatrics, Perinatology and Child Health 205
- Oncology 203
- Pharmacology 176
Countries citing papers authored by Victoria Rollason
This map shows the geographic impact of Victoria Rollason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Rollason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Rollason more than expected).
Fields of papers citing papers by Victoria Rollason
This network shows the impact of papers produced by Victoria Rollason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Rollason. The network helps show where Victoria Rollason may publish in the future.
Co-authorship network of co-authors of Victoria Rollason
This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Rollason. A scholar is included among the top collaborators of Victoria Rollason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Rollason. Victoria Rollason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 50 | |
| 7 | 4 | |
| 8 | 12 | |
| 9 | [Importance and specificity of pharmacovigilance in the pediatric population]. | 1 |
| 10 | 16 | |
| 11 | 10 | |
| 12 | 94 | |
| 13 | 1 | |
| 14 | 13 | |
| 15 | 40 | |
| 16 | 19 | |
| 17 | 37 | |
| 18 | 29 | |
| 19 | 254 | |
| 20 | 9 |
About Victoria Rollason
Victoria Rollason is a scholar working on Toxicology, Pharmacology and Geriatrics and Gerontology, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (19 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers) and Atrial Fibrillation Management and Outcomes (6 papers). The work is most often cited by research in Geriatrics and Gerontology (228 citations), Pharmacology (363 citations) and Family Practice (76 citations). Victoria Rollason has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Jules Desmeules, Nicole P. Vogt, Caroline Samer, Youssef Daali, Kuntheavy Ing Lorenzini, Camille Lenoir, Gürkan Kaya, Pierre Dayer, Valérie Piguet and Helena Pontes. Their work appears in journals such as Cochrane Database of Systematic Reviews, Clinical Pharmacology & Therapeutics and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.